How do you pay?

How to pay the least

Ask for the cash price

Vistogard

We didn’t find one.

  1. Ask your pharmacy for Vistogard’s cash price, and one or two other pharmacies too.

Compare every option

Question
Brand nameVistogard
Authorized genericuridine triacetate
Regular genericuridine triacetate
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Vistogard?
The original
–
–

Brand nameNo maker’s card

We didn’t find a savings card or cash price from Vistogard’s maker. Ask the pharmacy for Vistogard’s cash price. With insurance, ask what your plan charges.

Authorized genericNot sold

There isn’t one. An authorized generic is Vistogard itself, from the same company, sold without the brand name, and usually for less. For now Vistogard is the only choice; ask the pharmacy for its cash price, or your plan what it charges.

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, ask the pharmacy for Vistogard’s cash price, or your plan what it charges.

What it’s used for

What the FDA label says

VISTOGARD ® is a pyrimidine analog indicated for the emergency treatment of adult and pediatric patients:

  • following a fluorouracil or capecitabine overdose regardless of the presence of symptoms, or
  • who exhibit early-onset, severe or life-threatening toxicity affecting the cardiac or central nervous system, and/or early-onset, unusually severe adverse reactions (e.g., gastrointestinal toxicity and/or neutropenia) within 96 hours following the end of fluorouracil or capecitabine administration.

Limitations of use:

  • VISTOGARD is not recommended for the non-emergent treatment of adverse reactions associated with fluorouracil or capecitabine because it may diminish the efficacy of these drugs.
  • The safety and efficacy of VISTOGARD initiated more than 96 hours following the end of fluorouracil or capecitabine administration have not been established.

Source: the FDA label for Vistogard (BTG International Inc), March 31, 2026. Full label on DailyMed 

Good to know